Jonathan G. Stine, MD, MSc, FACP is a Global Clinical Program Lead (Senior Global Medical Director) at AstraZeneca and an internationally recognized expert in MASLD/MASH and hepatometabolic drug development. He leads liver disease development programs and strategy across AstraZeneca's portfolio and has authored more than 135 peer-reviewed publications while contributing to international clinical practice guidelines and biomarker qualification initiatives.